{"id":"W2167828574","doi":"10.1177/2040622313492810","title":"Teriflunomide in relapsing multiple sclerosis: therapeutic utility","year":2013,"lang":"en","type":"article","venue":"Therapeutic Advances in Chronic Disease","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":true,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Teriflunomide; Multiple sclerosis; Medicine; Discontinuation; Adverse effect; Glatiramer acetate; Dimethyl fumarate; Oncology; Intensive care medicine; Internal medicine; Fingolimod; Immunology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004498698,0.000401937,0.0006213921,0.0002981244,0.000123062,0.00005608046,0.0003267741,0.00009507234,0.0008827288],"category_scores_gemma":[0.0002764027,0.0003403087,0.0001651556,0.0005786711,0.0005305097,0.0007667371,0.0001606709,0.0005533345,0.000184917],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001216865,"about_ca_system_score_gemma":0.0005033403,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002339012,"about_ca_topic_score_gemma":0.0003885847,"domain_scores_codex":[0.9967192,0.0002490246,0.0006724928,0.0007487368,0.0005693538,0.001041159],"domain_scores_gemma":[0.9981052,0.000438689,0.000117809,0.0008421404,0.0001032584,0.0003929329],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.001144748,0.0007377975,0.3294277,0.0005338262,0.00006832404,0.00003308906,0.0003736388,0.0003723252,0.008673972,0.0001114247,0.00004313964,0.6584799],"study_design_scores_gemma":[0.006553965,0.0001806687,0.9583383,0.001215933,0.00004864604,0.000002015229,0.0003640956,0.02329184,0.0004428433,0.002636788,0.006541232,0.0003836525],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.8065594,0.1833747,0.0008102127,0.002386904,0.0003271651,0.003629409,0.00002712968,0.0002301933,0.002654829],"genre_scores_gemma":[0.9835452,0.01425128,0.0002935073,0.0006863045,0.0001495646,0.0008200903,0.0000170944,0.00006048444,0.0001764929],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.6580963,"threshold_uncertainty_score":0.9999049,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.07470561988529514,"score_gpt":0.346559401018863,"score_spread":0.2718537811335678,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}